A research-based biopharmaceutical company, Gilead Sciences, discovers, produces and markets innovative healthcare products that are capable of transforming and simplifying medical care for people, who suffer from life-threatening diseases globally.
Gilead Sciences was established in June 1987. The company primarily focused on antiviral medicines. It concentrated on gene therapy, estimating the potential of genetic code blockers. The development and research of small molecule antiviral therapeutics started in 1991 with licensing of a group of nucleotide compounds (tenofovir was one of them) that further became widely-used anti-retroviral medicines. In 1990, Gilead collaborated with Glaxo for the development and research of genetic code blockers, known as antisense.
Gilead Sciences was founded by Michael L. Riordan, a 29-year-old doctor, who graduated from the Johns Hopkins School of Medicine, Washington University of St. Louis and the Harvard Business School. Riordan worked as the company’s CEO from its inception till 1996.
Headquartered in Foster City, California, US, the company operates across 6 continents and has a team of almost 9,000 employees. Gilead has a portfolio of 24 marketed products and is rapidly expanding. The research and development division works on over 400 clinical studies, evaluating compounds that potentially will become the next generation of efficient medicines.
Gilead Sciences shares are listed and traded on the NASDAQ stock exchange under the ticker symbol GILD. The company is a component of the NASDAQ-100, S&P 500 and S&P 100 indices. Join Capital.com to trade CFDs on the Gilead Sciences share price fluctuations and follow the GILD chart in real-time.
Start trading today
CFDs allow you to benefit from all the price fluctuations of a product without ever having to own the product itself. Never worry about liquidity issues, or whether an exchange is down, by trading CFDs.
Our revolutionary AI technology helps you be a better trader by highlighting if you’re trading with a bias.
Our state of the art app is designed with you in mind providing great execution as standard. Personalise it so you can do everything you want instantly.
Investmate brings you personalised, up to date educational material on the go, to help you avoid biases, and become a better trader.
We focus on providing you with peace of mind. Negative balance protection ensures your losses will never exceed what’s in your account.
We cover all the charges so you can keep more of your money to trade the markets
We’re here 24 hours a day for you. Anything that you need, we are here to solve